Testing effectiveness (Phase 2)Study completedNCT00285103What this trial is testingSPC2996 in Chronic Lymphocytic LeukaemiaWho this might be right forChronic Lymphocytic Leukemia Santaris Pharma A/S 46
Large-scale testing (Phase 3)Study completedNCT03406156What this trial is testingA Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination TherapyWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) AbbVie 120
Testing effectiveness (Phase 2)Ended earlyNCT02258529What this trial is testingIdelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic LymphomaWho this might be right forFollicular LymphomaSmall Lymphocytic Lymphoma Gilead Sciences 10
Not applicableNot Yet RecruitingNCT07759661What this trial is testingInnovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination TherapiesWho this might be right forChronic Lymphocytic Leukemia (CLL)Splenic Marginal Zone LymphomaHairy Cell Leukemia (HCL) IRCCS San Raffaele 64
Not applicableEnded earlyNCT00965861What this trial is testingSCRI Tissue Testing RegistryWho this might be right forMelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more SCRI Development Innovations, LLC 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03534323What this trial is testingDuvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RSWho this might be right forChronic Lymphocytic LeukemiaRichter Syndrome Dana-Farber Cancer Institute 55
Early research (Phase 1)Ended earlyNCT04804254What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell CancersWho this might be right forB-cell Lymphoma AbbVie 5
Testing effectiveness (Phase 2)Study completedNCT00738829What this trial is testingLenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLLWho this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Arbeitsgemeinschaft medikamentoese Tumortherapie 45
Testing effectiveness (Phase 2)Study completedNCT01011894What this trial is testingLenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of AgeWho this might be right forChronic Lymphocytic LeukemiaLeukemia Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)WithdrawnNCT01754870What this trial is testingPhase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)Who this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00004002What this trial is testingPS-341 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific NYU Langone Health
Testing effectiveness (Phase 2)UnknownNCT03467256What this trial is testingCD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALLWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia, Pediatric Federal Research Institute of Pediatric Hematology, Oncology and Immunology 18
Not applicableStudy completedNCT01178086What this trial is testingA Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)Who this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 681
Early research (Phase 1)WithdrawnNCT05037669What this trial is testingProgrammed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and LymphomaWho this might be right forAcute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma University of Pennsylvania
Testing effectiveness (Phase 2)Study completedNCT00005854What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06764238What this trial is testingNewly-diagnosed Intermediate/High Risk Pediatric B-cell ALL ProtocolWho this might be right forAcute Lymphoblastic Leukemia ALLChildhood Leukemia, Acute LymphoblasticB Cell Acute Lymphoblastic Leukemia (B-ALL) Institute of Hematology & Blood Diseases Hospital, China 1,800
Not applicableNot Yet RecruitingNCT07463976What this trial is testingVariaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia PathwayWho this might be right forChronic Lymphocytic LeukemiaHaematological Malignancy The Royal Wolverhampton Hospitals NHS Trust 130
Early research (Phase 1)Ended earlyNCT00882076What this trial is testingClofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasWho this might be right forLeukemia Milton S. Hershey Medical Center 22
Early research (Phase 1)UnknownNCT01619761What this trial is testingNK Cells in Cord Blood TransplantationWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00004061What this trial is testingBiological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerWho this might be right forLeukemiaLymphomaOral Complications Memorial Sloan Kettering Cancer Center 111